View in EDS

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.

Saved in:
Bibliographic Details
Title: Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.
Authors: Combe B; Rheumatology, CHU Montpellier, Montpellier, France bernard.combe@umontpellier.fr., Kivitz A; Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA., Tanaka Y; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., van der Heijde D; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands., Simon JA; Köhler & Milstein Research, Mérida, Mexico., Baraf HSB; The Center for Rheumatology and Bone Research, Wheaton, Maryland, USA., Kumar U; Rheumatology, All India Institute of Medical Sciences, New Delhi, India., Matzkies F; Gilead Sciences, Foster City, California, USA., Bartok B; Gilead Sciences, Foster City, California, USA., Ye L; Gilead Sciences, Foster City, California, USA., Guo Y; Gilead Sciences, Foster City, California, USA., Tasset C; Galapagos NV, Mechelen, Belgium., Sundy JS; Gilead Sciences, Foster City, California, USA.; Medicine, Duke University Medical Center, Durham, North Carolina, USA., Jahreis A; Gilead Sciences, Foster City, California, USA., Genovese MC; Gilead Sciences, Foster City, California, USA., Mozaffarian N; Ichnos Sciences, New York, New York, USA., Landewé RBM; Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Bae SC; Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea., Keystone EC; Medicine, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada., Nash P; Griffith University, Brisbane, Queensland, Australia.
Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Jul; Vol. 80 (7), pp. 848-858. Date of Electronic Publication: 2021 Jan 27.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33504485
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Combe+B%22">Combe B</searchLink>; Rheumatology, CHU Montpellier, Montpellier, France bernard.combe@umontpellier.fr.<br /><searchLink fieldCode="AU" term="%22Kivitz+A%22">Kivitz A</searchLink>; Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Tanaka+Y%22">Tanaka Y</searchLink>; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.<br /><searchLink fieldCode="AU" term="%22van+der+Heijde+D%22">van der Heijde D</searchLink>; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Simon+JA%22">Simon JA</searchLink>; Köhler & Milstein Research, Mérida, Mexico.<br /><searchLink fieldCode="AU" term="%22Baraf+HSB%22">Baraf HSB</searchLink>; The Center for Rheumatology and Bone Research, Wheaton, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Kumar+U%22">Kumar U</searchLink>; Rheumatology, All India Institute of Medical Sciences, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Matzkies+F%22">Matzkies F</searchLink>; Gilead Sciences, Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Bartok+B%22">Bartok B</searchLink>; Gilead Sciences, Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Ye+L%22">Ye L</searchLink>; Gilead Sciences, Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Guo+Y%22">Guo Y</searchLink>; Gilead Sciences, Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Tasset+C%22">Tasset C</searchLink>; Galapagos NV, Mechelen, Belgium.<br /><searchLink fieldCode="AU" term="%22Sundy+JS%22">Sundy JS</searchLink>; Gilead Sciences, Foster City, California, USA.; Medicine, Duke University Medical Center, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Jahreis+A%22">Jahreis A</searchLink>; Gilead Sciences, Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Genovese+MC%22">Genovese MC</searchLink>; Gilead Sciences, Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Mozaffarian+N%22">Mozaffarian N</searchLink>; Ichnos Sciences, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Landewé+RBM%22">Landewé RBM</searchLink>; Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bae+SC%22">Bae SC</searchLink>; Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Keystone+EC%22">Keystone EC</searchLink>; Medicine, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Nash+P%22">Nash P</searchLink>; Griffith University, Brisbane, Queensland, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372355%22">Annals of the rheumatic diseases</searchLink> [Ann Rheum Dis] 2021 Jul; Vol. 80 (7), pp. 848-858. <i>Date of Electronic Publication: </i>2021 Jan 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372355 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-2060 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200034967%22">00034967 </searchLink><i>NLM ISO Abbreviation: </i>Ann Rheum Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33504485
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/annrheumdis-2020-219214
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 848
    Titles:
      – TitleFull: Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Combe B
      – PersonEntity:
          Name:
            NameFull: Kivitz A
      – PersonEntity:
          Name:
            NameFull: Tanaka Y
      – PersonEntity:
          Name:
            NameFull: van der Heijde D
      – PersonEntity:
          Name:
            NameFull: Simon JA
      – PersonEntity:
          Name:
            NameFull: Baraf HSB
      – PersonEntity:
          Name:
            NameFull: Kumar U
      – PersonEntity:
          Name:
            NameFull: Matzkies F
      – PersonEntity:
          Name:
            NameFull: Bartok B
      – PersonEntity:
          Name:
            NameFull: Ye L
      – PersonEntity:
          Name:
            NameFull: Guo Y
      – PersonEntity:
          Name:
            NameFull: Tasset C
      – PersonEntity:
          Name:
            NameFull: Sundy JS
      – PersonEntity:
          Name:
            NameFull: Jahreis A
      – PersonEntity:
          Name:
            NameFull: Genovese MC
      – PersonEntity:
          Name:
            NameFull: Mozaffarian N
      – PersonEntity:
          Name:
            NameFull: Landewé RBM
      – PersonEntity:
          Name:
            NameFull: Bae SC
      – PersonEntity:
          Name:
            NameFull: Keystone EC
      – PersonEntity:
          Name:
            NameFull: Nash P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2021 Jul
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1468-2060
          Numbering:
            – Type: volume
              Value: 80
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Annals of the rheumatic diseases
              Type: main
ResultId 1